Why Attend the World Immune Tolerance Week?
For 10 years, the Antigen-Specific Immune Tolerance Summit has been the dedicated meeting point for the scientists, pharma leaders, biotech innovators, and clinicians, biotech innovators, and pharma leaders advancing precision immune tolerance therapies for autoimmune disease and allergy.
In 2027, the summit enters its next chapter as part of World Immune Tolerance Week, alongside the 9th Treg-Directed Therapies Summit and the 2nd Immune Resetting: B-Cell Mediated & Beyond Summit. While each summit will retain its own scientific focus and depth of content, attendees can now explore adjacent approaches while connecting with a broader network of autoimmune and immunology experts. With one registration, you will join the World Immune Tolerance Week and gain access to the sessions and networking opportunities across the three summits.
Why World Immune Tolerance Week?
The immunology field is increasingly recognizing that long-term disease control may be achieved through multiple mechanisms that reprogram or reset immune function. While scientific approaches differ, the ultimate objective remains the same: Restoring Lasting Immune Tolerance for Patients With Autoimmune Disease.
To reflect this rapidly evolving landscape, the 10th Antigen-Specific Immune Tolerance Summit, 9th Treg-Directed Therapies Summit, and 2nd Immune Resetting: B-Cell Mediated & Beyond Summit are coming together as World Immune Tolerance Week.
Each community addresses a different piece of the immune tolerance puzzle:
Dedicated to advancing precision antigen-specific therapies through breakthroughs in clinical translation, biomarkers, efficacy, durability, and delivery technologies.
Focused on accelerating next-generation regulatory T-cell therapies and translating advances in Treg biology into predictable clinical success.
Exploring the latest approaches to immune resetting, durable remission, B-cell depletion, and immune reprogramming in autoimmune disease.
These communities are distinct, but increasingly interconnected. Bringing them together creates a unique opportunity to share insights, meet new potential collaborators, and accelerate progress across autoimmune and inflammatory disease.
The Best of Both Worlds
World Immune Tolerance Week has been designed to preserve the depth of scientific presentations at each conference while creating opportunities for greater collaboration across the wider autoimmune community.
Every summit maintains its own unique:
- Agenda
- Speaker Faculty
- Community Identity
- Technical Discussions
Attendees continue to receive the focused experience that has made each meeting valuable, while gaining access to adjacent scientific perspectives, new networking opportunities, and a broader group of stakeholders working to advance immune tolerance in autoimmune disease.
Whether you are exploring tolerance biomarkers, cell engineering approaches, immune monitoring strategies, future combination opportunities, or potential partnering and collaboration, World Immune Tolerance Week provides visibility into scientific advances beyond your immediate area of focus.
What You Gain as an Attendee
Access Scientific Perspectives Beyond Your Own Approach
Understand how antigen-specific approaches fit within the wider immune tolerance landscape and discover emerging innovations that may influence future development strategies.
Build Relationships Across the Autoimmune Community
Meet a larger pool of biotech executives, translational scientists, pharma immunology teams, investors, and strategic partners working across autoimmune disease.
Discover New Partnership Opportunities
Identify partners developing complementary technologies, platforms, biomarkers, manufacturing solutions, and clinical capabilities.
Increase Your Visibility Among Key Decision-Makers
Engage with senior stakeholders from across the autoimmune and immunology ecosystem who may not have previously attended a dedicated antigen-specific event.
Who Will You Meet?
By uniting three distinct audiences, the World Immune Tolerance Week will help you connect with a broader range of experts and maximize your networking opportunities.
Attendee Titles Include:
- Chief Executive Officer
- Chief Scientific Officer
- Chief Medical Officer
- Vice President – Immunology
- Medical Director – Immunology
- Principal / Senior Scientist
- Global Head of Immune Tolerance
Attending Companies Include
